AWA
NAGE

Arete Wealth Advisors’s Niagen Bioscience NAGE Stock Holding History

Arete Wealth Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-44,924
Closed -$177K – 434
2019
Q3 		$177K Sell
44,924
-5,000
-10% -$21.3K 0.03% 386
2019
Q2 		$232K Sell
49,924
-3,334
-6% -$14.2K 0.05% 340
2019
Q1 		$223K Hold
53,258
– – 0.05% 338
2018
Q4 		$183K Hold
53,258
– – 0.04% 339
2018
Q3 		$228K Sell
53,258
-8,334
-14% -$35.8K 0.05% 319
2018
Q2 		$229K Buy
61,592
+2,333
+4% +$8.86K 0.05% 324
2018
Q1 		$249K Hold
59,259
– – 0.08% 269
2017
Q4 		$348K Sell
59,259
-3,334
-5% -$18K 0.11% 214
2017
Q3 		$269K Hold
62,593
– – 0.11% 210
2017
Q2 		$239K Sell
62,593
-2,500
-4% -$7.92K 0.11% 206
2017
Q1 		$175K Hold
65,093
– – 0.08% 192
2016
Q4 		$215K Buy
+65,093
New +$177K 0.1% 163

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MFCM
Mercator Fund (Cayman Master) New York $125M AUM
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return

Arete Wealth Advisors's NAGE Position: Q4 2019 in Review

Arete Wealth Advisors sold out of Niagen Bioscience (NAGE) in Q4 2019, closing a stake of 44,924 shares — an estimated $177K sold.

Arete Wealth Advisors first reported a position in NAGE in Q4 2016 and held it in 12 quarters. The position peaked at $348K in Q4 2017. 65 funds tracked by Wall St. Rank hold NAGE as of Q4 2019.

  • Arete Wealth Advisors reported no remaining Niagen Bioscience position as of Q4 2019 after selling out during the quarter.
  • Arete Wealth Advisors sold 44,924 Niagen Bioscience shares in Q4 2019, an estimated $177K.
  • Arete Wealth Advisors first reported a position in Niagen Bioscience in Q4 2016 and held it in 12 quarters.
  • Arete Wealth Advisors's Niagen Bioscience position peaked at $348K in Q4 2017.
  • 65 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2019.

Based on Arete Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.